These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9873535)

  • 61. Polycationic peptides as inhibitors of mast cell serine proteases.
    Lundequist A; Juliano MA; Juliano L; Pejler G
    Biochem Pharmacol; 2003 Apr; 65(7):1171-80. PubMed ID: 12663052
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors.
    Dudley DA; Bunker AM; Chi L; Cody WL; Holland DR; Ignasiak DP; Janiczek-Dolphin N; McClanahan TB; Mertz TE; Narasimhan LS; Rapundalo ST; Trautschold JA; Van Huis CA; Edmunds JJ
    J Med Chem; 2000 Nov; 43(22):4063-70. PubMed ID: 11063603
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Solid-phase synthesis of a library based on biphenyl-containing trypsin-like serine protease inhibitors.
    Shi S; Zhu S; Gerritz SW; Rachwal B; Ruan Z; Hutchins R; Kakarla R; Sofia MJ; Sutton J; Cheney D
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6477-80. PubMed ID: 19804972
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase.
    Enyedy IJ; Lee SL; Kuo AH; Dickson RB; Lin CY; Wang S
    J Med Chem; 2001 Apr; 44(9):1349-55. PubMed ID: 11311057
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
    Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
    Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design and synthesis of bicyclic pyrimidinone-based HCV NS3 protease inhibitors.
    Glunz PW; Douty BD; Decicco CP
    Bioorg Med Chem Lett; 2003 Mar; 13(5):785-8. PubMed ID: 12617891
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.
    Katz BA; Elrod K; Verner E; Mackman RL; Luong C; Shrader WD; Sendzik M; Spencer JR; Sprengeler PA; Kolesnikov A; Tai VW; Hui HC; Breitenbucher JG; Allen D; Janc JW
    J Mol Biol; 2003 May; 329(1):93-120. PubMed ID: 12742021
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications.
    Plummer JS; Berryman KA; Cai C; Cody WL; DiMaio J; Doherty AM; Edmunds JJ; He JX; Holland DR; Levesque S; Kent DR; Narasimhan LS; Rubin JR; Rapundalo ST; Siddiqui MA; Susser AJ; St-Denis Y; Winocour PD
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3409-14. PubMed ID: 9873743
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis of macrocyclic, potential protease inhibitors using a generic scaffold.
    Dumez E; Snaith JS; Jackson RF; McElroy AB; Overington J; Wythes MJ; Withka JM; McLellan TJ
    J Org Chem; 2002 Jul; 67(14):4882-92. PubMed ID: 12098301
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combinatorial approaches towards the discovery of new tryptase inhibitors.
    del Fresno M; Fernández-Forner D; Miralpeix M; Segarra V; Ryder H; Royo M; Albericio F
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1659-64. PubMed ID: 15745817
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
    Krishnan R; Zhang E; Hakansson K; Arni RK; Tulinsky A; Lim-Wilby MS; Levy OE; Semple JE; Brunck TK
    Biochemistry; 1998 Sep; 37(35):12094-103. PubMed ID: 9724521
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme factor Xa.
    Phillips GB; Buckman BO; Davey DD; Eagen KA; Guilford WJ; Hinchman J; Ho E; Koovakkat S; Liang A; Light DR; Mohan R; Ng HP; Post JM; Shaw KJ; Smith D; Subramanyam B; Sullivan ME; Trinh L; Vergona R; Walters J; White K; Whitlow M; Wu S; Xu W; Morrissey MM
    J Med Chem; 1998 Sep; 41(19):3557-62. PubMed ID: 9733480
    [No Abstract]   [Full Text] [Related]  

  • 73. Design and chemical syntheses of potent matriptase-2 inhibitors based on trypsin inhibitor SFTI-1 isolated from sunflower seeds.
    Gitlin-Domagalska A; Dębowski D; Łęgowska A; Stirnberg M; Okońska J; Gütschow M; Rolka K
    Biopolymers; 2017 Nov; 108(6):. PubMed ID: 28555756
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A novel approach to serine protease inhibition: kinetic characterization of inhibitors whose potencies and selectivities are dramatically enhanced by Zinc(II).
    Janc JW; Clark JM; Warne RL; Elrod KC; Katz BA; Moore WR
    Biochemistry; 2000 Apr; 39(16):4792-800. PubMed ID: 10769136
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1.
    Li P; Jiang S; Lee SL; Lin CY; Johnson MD; Dickson RB; Michejda CJ; Roller PP
    J Med Chem; 2007 Nov; 50(24):5976-83. PubMed ID: 17985858
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Design and synthesis of indole and tetrahydroisoquinoline hydantoin derivatives as human chymase inhibitors.
    Alagille D; Pfeiffer B; Scalbert E; Ferry G; Boutin JA; Renard P; Viaud-Massuard MC
    J Enzyme Inhib Med Chem; 2004 Apr; 19(2):137-43. PubMed ID: 15449728
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tripeptides with non-code amino acids as potential serine proteases inhibitors.
    Markowska A; Bruzgo M; Surażyński A; Midura-Nowaczek K
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):639-43. PubMed ID: 22299583
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tetra-p-amidinophenoxy-propane as a probe of the specificity site of serine proteases.
    Menegatti E; Guarneri M; Ferroni R; Bolognesi M; Ascenzi P; Antonini E
    FEBS Lett; 1982 May; 141(1):33-6. PubMed ID: 7044822
    [No Abstract]   [Full Text] [Related]  

  • 79. 2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease.
    Hays SJ; Caprathe BW; Gilmore JL; Amin N; Emmerling MR; Michael W; Nadimpalli R; Nath R; Raser KJ; Stafford D; Watson D; Wang K; Jaen JC
    J Med Chem; 1998 Mar; 41(7):1060-7. PubMed ID: 9544206
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design, synthesis and biological activity of a targeted library of potential tryptase inhibitors.
    García M; del Rio X; Silvestre S; Rubiralta M; Lozoya E; Segarra V; Fernández D; Miralpeix M; Aparici M; Diez A
    Org Biomol Chem; 2004 Jun; 2(11):1633-42. PubMed ID: 15162216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.